| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.071 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |